Rise In Rare Disease Diagnoses Fueling The Growth Of The Market Due To Improving Genetic Testing And Diagnostics: The Driving Engine Behind Angioedema Treatment Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Angioedema Treatment Market Size Growth Forecast: What to Expect by 2025?
The market size for angioedema treatment has experienced swift expansion over the recent past. Forecasts suggest an increase from $2.72 billion in 2024 to $3.13 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.0%. Factors driving this growth during the historical period include increased governmental backing, heightened diagnosis rates, a spike in autoimmune disorders, acceleration in clinical trials, and healthcare infrastructure expansion.

How Will the Angioedema Treatment Market Size Evolve and Grow by 2029?
The market for angioedema treatment is projected to experience swift expansion in the forthcoming years, with expectations to surge to $5.4 billion by 2029, boasting a compound annual growth rate (CAGR) of 14.6%. The escalation projected in this period stems from an increase in healthcare spending, heightened awareness of allergies, rising prevalence of chronic ailments, escalating incidences of angioedema, and a growing emphasis on personalized healthcare. Key trends for the forecasted timeline include progress in diagnostic technology, the merge with machine learning, funding in research and development, the incorporation of telemedicine, and swift market access fueled by regulatory approvals.

View the full report here:
https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

What Drivers Are Propelling the Growth of Angioedema Treatment Market Forward?
The increase in rare illnesses is anticipated to drive the angioedema treatment market expansion forward. These rare conditions, which only affect a small portion of the populace and often have limited therapeutic solutions, can have severe health consequences. The increased incidence of these diseases is due to advancements in genetic testing and diagnostic technology, allowing healthcare professionals to identify and correctly diagnose conditions previously ignored, resulting in a higher reported occurrence. Angioedema treatments improve patient outcomes by providing targeted therapies that mitigate and handle severe swelling incidents linked with rare diseases such as hereditary angioedema. For instance, the Food and Drug Administration, a federal agency in the United States, stated in November 2024 that over 7,000 rare illnesses affected more than 30 million Americans. Consequently, the rise in the incidence of rare diseases is stimulating the angioedema treatment market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

Which Emerging Trends Are Transforming the Angioedema Treatment Market in 2025?
Prominent businesses in the angioedema treatment market are prioritizing the development of groundbreaking solutions, like subcutaneous injections, to deliver faster and handier relief to individuals afflicted with acute hereditary angioedema (HAE) attacks. Subcutaneous injections represent a strategy to administer medicine into the fatty tissue just below the skin, enabling a gradual and consistent diffusion into the bloodstream. For example, in April 2025, Australia-based biotech corporation, CSL Limited, debuted ANDEMBRY(garadacimab), a novel, fully human monoclonal antibody therapy for preventing acute episodes in patients with hereditary angioedema (HAE). ANDEMBRY marks the maiden pre-filled pen for once-monthly subcutaneous use, presenting a convenient option for long-term preventive care. The drug functions by obstructing activated Factor XII (Factor XIIa), a significant initiator in the cascade resulting in angioedema. This signifies a substantial milestone in HAE management by affording efficient, patient-focused disease management.

What Are the Key Segments in the Angioedema Treatment Market?
The angioedema treatment market covered in this report is segmented -

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema
2) By Route Of Administration: Injection, Oral
3) By End Use: Hospitals, Clinics, Research Organizations

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies
2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors
3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management
4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

Who Are the Key Players Shaping the Angioedema Treatment Market's Competitive Landscape?
Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

What Geographic Markets Are Powering Growth in the Angioedema Treatment Market?
North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24460

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.